Form 8-K - Current report:
SEC Accession No. 0000950170-25-073967
Filing Date
2025-05-19
Accepted
2025-05-19 08:30:10
Documents
10
Period of Report
2025-05-15
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K crbp-20250515.htm   iXBRL 8-K 79301
  Complete submission text file 0000950170-25-073967.txt   194380

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT crbp-20250515.xsd EX-101.SCH 31270
12 EXTRACTED XBRL INSTANCE DOCUMENT crbp-20250515_htm.xml XML 4767
Mailing Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001595097 (see all company filings)

EIN.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37348 | Film No.: 25961577
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)